Medicare, AARP

Weight-loss drugs like Ozempic may be up for Medicare price negotiations — will Trump support it?
Medicare’s drug pricing negotiations — the first of their kind in the United States, passed under President Joe Biden — face an uncertain future in the incoming Trump administration.
Prices of top 25 Medicare Part D drugs have nearly doubled, AARP study finds
AARP's new research finds price growth for top Part D prescription drugs has exceeded inflation, making a case for allowing Medicare to negotiate prices.
New AARP Report: Top Medicare Part D Drugs See Average Lifetime Price Hike of 98%
Findings show the impact of drug companies’ relentless price increases, underscoring the importance of the changes included in the historic 2022 drug law
Medicare Drug Price Explanations Shed Some Light on Future Talks
The Biden administration’s justification of the first cycle of Medicare drug price negotiations is fueling curiosity and uncertainty about a process largely held behind closed doors, just as another round of talks begin in the coming weeks under a new administration.
Ozempic, Trulicity among Medicare's priciest drugs, report finds
Popular diabetes drugs such as Ozempic and Trulicity are among 25 drugs Medicare has spent the most on but hasn't yet selected for price negotiation, according to a report released Thursday. The report from AARP Public Policy Institute said average list prices on these 25 drugs have nearly doubled since they hit the market and collectively cost Medicare ‒ and American taxpayers ‒ nearly $50 billion in 2022.
Drugs not selected for Medicare price negotiation nearly doubled - report
The list prices of the top 25 drugs with the highest Medicare Part D spend that are not subject to drug price negotiations have increased by an average 98% since they hit the market, according to a new report.
25 Top Medicare Part D Drugs Have Nearly Doubled in Price
People with Medicare Part D plans shoulder a share of the cost of their prescription drugs. Under the standard Part D benefit, enrollees are responsible for 25 percent of their dr
Here We Go Again: The Medicare Advantage Open Enrollment Period
The Medicare Advantage Open Enrollment Period (Jan 1–Mar 31) lets you switch plans or adjust coverage. Review your options to ...
Eli Lilly's obesity drug gets Medicare coverage for sleep apnea
Eli Lilly's obesity drug Zepbound can now be covered by government-backed Medicare insurance plans for use in sleep apnea, ...
Medicare enrollees throughout U.S. getting relief in prescription drug costs in 2025
RAPID CITY, S.D. (KOTA) - It’s the dawn of a new age as Medicare enrollees will be able to save a lot of money on their prescription drugs. “For those that are on the lower end of the fixed-income ...
Mastering Medicare Appeals: Your Guide to Overturning Denials
On the other hand, Medicare Advantage plans have a more nuanced process. These plans require prior approval for all claims, making the insurance carrier the first point of contact for denials. While ...
McKnight's Senior Living7h
Medicare patients wait average of 34 days to see neurologist after referral
Patients with Parkinson's disease, multiple sclerosis and epilepsy have to wait longer than those with back pain.
Hints from Heloise: Beware of Medicare card scams
Three days ago, a woman called me and asked if I had received my new or updated Medicare card. I said I had not, nor had I ...
Medicare Expands Coverage of Eli Lilly’s Weight-Loss Drug
Eli Lilly’s popular anti-obesity drug Zepbound could get a sales boost after the U.S. Medicare program decided to pay for its use to treat sleep apnea. The Centers f ...
federalnewsnetwork.com1d
Feds With Benefits: Making Medicare decisions at 65
Question: If someone is on Federal Health Benefits, what happens when they turn 65 and become eligible for Medicare?
Does Medicare cover mental health services?
How does Medicare cover outpatient and inpatient mental health care services and programs to help beneficiaries with anxiety, ...